Stifel Reports April 2026 Operating Data
Does Your Firm Recommend Structured Notes? Finra Has Some Questions for You.
How The Pet Valu Holdings (TSX:PET) Story Is Shifting As Analyst Expectations Reset
Hemlo Mining Maintained at Buy at Stifel Canada After Q1 Results; Price Target Kept atC$12.00
Aya Gold & Silver Maintained at Buy at Stifel Canada After Boumadine Drill Results; Price Target Kept at C$39.00
Superior Plus Maintained at Buy at Stifel Canada Following Q1 Results; Price Target Raised to C$10.00
Stifel Reaches Settlement in Structured Notes Case
How The Orthofix Medical (OFIX) Investment Story Is Resetting After New Guidance And Targets
How The DocGo (DCGO) Story Is Shifting As Transport Optimism Meets Lower Valuation Targets
Whitehawk Therapeutics to Participate in 2026 Stifel Virtual Targeted Oncology Forum
MacroGenics to Participate in the Stifel 2026 Virtual Targeted Oncology Forum
Stifel cuts outlook on Under Armour as turnaround faces delays
Stifel Project Finance Launch Ties Valuation Debate To Energy Transition
IsoEnergy Maintained at Buy a Stifel Canada Following Larocque-East Drill Results; Price Target Kept at C$27.00
Algoma Steel Group Maintained at Buy at Stifel Canada Following Q1 Results; Price Target Kept at C$11.50
Neo Performance Materials Maintained at Buy at Stifel Canada After Q1 Results; Price Target Raised to C$38.00
K92 Mining Maintained at Buy at Stifel Canada Following Q1 Results; Price Target Kept at C$39.00
Barrick Mining Maintained at Buy at Stifel Canada After Q1 Results; Price Target Kept at C$95.00
Stifel Canada Lifts NFI Group Price Target by $0.50 to $26.00
Cloudbreak Pharma to Present at the Stifel 2026 Virtual Ophthalmology Forum
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.